| Literature DB >> 35260597 |
Ali Akbar Haghdoost1, Farshad Farzadfar2, Moein Yoosefi2, Kamyar Mansori3, Bagher Larijani4, Mohammad Reza Baneshi5, Fatemeh Khosravi Shadmani6.
Abstract
The present study investigates different scenarios to project the chance of achieving SDG 3.4 in Iran. In this study, the Iranian Death Registry System data was employed to estimate the Unconditional Probability of Dying (UPoD) for the four major categories of NCDs; then, the Bayesian model averaging was used to project the UPoD at the national and sub-national levels. Also, the prevalence of the risk factors was projected by 2030 based on STEPs as well as some other study data. Plus, UPoD and the possibility of achieving the target were estimated once again based on the assumption that the global reduction in risk factors proposed by WHO would be adopted in Iran. The UPoDs for the four NCDs in Iran were 17.5% (95% UI: 16.3-19.2) and 14.7% (13.3-16.2) in 2010 and 2015 respectively and if the current trend continues, 2030 will mark the UPoD of 10.8% (7.9-14.3). However, If the risk factors are reduced to the WHO target level by 2030, the UPoDs will be reduced to 5.44% (3.51-7.39) and 6.55% (5.00-8.13) of the 2010 and 2015 baseline scenarios, respectively, to enable some provinces to meet SDG 3.4. If the current trend continues, Iran will and will not achieve the SDG 3.4 in 2010 and 2015 baseline scenarios, respectively. However, if the global target set for reducing risk factors is achieved, Iran will meet all expectations in SDG 3.4 except in Asthma and COPD. Therefore, effective interventions are recommended to be designed and followed to reduce Asthma and COPD.Entities:
Mesh:
Year: 2022 PMID: 35260597 PMCID: PMC8904528 DOI: 10.1038/s41598-022-07441-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Study workflow in current situation.
Figure 2Study workflow in WHO-based scenario.
All characteristics of risk factors, WHO targets and theoretical minimum risk exposure level.
| Risk factor | Exposure definition | Data source | Related disease | WHO target for risk factors | Theoretical minimum risk exposure level (TMREL) |
|---|---|---|---|---|---|
| High systolic and diastolic blood pressure | Mean of systolic and diastolic blood pressure, measured in mmHg | STEPs surveys (from 2005 to 2009–2011–2016) An additional studies: GCS1, IHHP2, MONICA3, NHS4,TLGS5 | Rheumatic heart disease, Hypertensive heart disease, ischemic heart disease, ischemic stroke, hemorrhagic and other non-ischemic stroke, cardiomyopathy, myocarditis, endocarditis, atrial fibrillation and flutter, other circulatory diseases, chronic obstructive pulmonary disease, kidney disease | 25% relative reduction in the prevalence of raised blood pressure | 110–115 mm Hg |
| High FPG | Mean of serum fasting plasma glucose measured in mg/dl | STEPs surveys (from 2005 to 2009–2011–2016) An additional studies: GCS, IHHP, MONICA, NHS,TLGS | Diabetes mellitus, Ischemic heart disease, Ischemic stroke, Hemorrhagic and other non-ischemic stroke, Kidney disease | Halt the rise in diabetes | 4·8–5·4 mmol/L |
| Obesity and overweight | Mean of body mass index, measured in kg/m2 | STEPs surveys (from 2005 to 2009–2011–2016) An additional studies: an additional studies: GCS, IHHP, MONICA, NHS,TLGS | Colon and rectum cancers, liver cancer, pancreas cancer, breast cancer, corpus uteri cancer, ovary cancer, prostate cancer, non-hodgkin lymphoma, other lymphomas and multiple myeloma, leukemia, kidney cancer, gallbladder cancer, thyroid cancer, diabetes mellitus, hypertensive heart disease, ischemic heart disease, ischemic stroke, hemorrhagic and other non-ischemic stroke, kidney disease | Halt the rise in obesity | 21–25 kg/m2 |
| Physical inactivity | Average weekly physical activity at work, home, transport-related, and recreational measured by MET min per week | STEPs surveys ( from 2005 to 2009–2011–2016) | Colon and rectum cancers, breast cancer, diabetes mellitus, ischemic heart disease, ischemic stroke | 10% reduction in the prevalence of physical inactivity | All adults experience 3000–4500 MET min per week |
| Smoking | Daily smoking Smoking Impact ratio(SIR) | STEPs surveys (from 2005 to 2009–2011–2016) | Mouth and oropharynx cancers, esophagus cancer, stomach cancer, colon and rectum cancers, liver cancer, pancreas cancer Trachea, bronchus and lung cancers, melanoma and other skin cancers, breast cancer, cervix uteri cancer, corpus uteri cancer, ovary cancer, prostate cancer, bladder cancer, non-hodgkin lymphoma, multiple myeloma, other lymphomas and multiple myeloma, leukemia, kidney cancer, gallbladder cancer, thyroid cancer, diabetes mellitus, rheumatic heart disease, hypertensive heart disease, ischemic heart disease, ischemic stroke, hemorrhagic and other non-ischemic stroke, chronic obstructive, pulmonary disease, asthma, other respiratory diseases | 30% relative reduction in the prevalence of current tobacco use | All individuals are lifelong non-smokers |
| Salt intake | 24 h urinary sodium measured in gram per day Mean of salt intake | STEPs in 2016 Comprehensive project on household food pattern and nutritional status, TLGS, IHHP, Isfahan salt study, PGHHS6, Mashhad Study, YHHP7, Urban Health Equity assessment and Response Tool (Urban Heart-phase1), HIEs8 | Direct : stomach cancer Indirect : rheumatic heart disease, hypertensive heart disease, ischemic heart disease, ischemic stroke, hemorrhagic and other non-ischemic stroke, cardiomyopathy, myocarditis, endocarditis, atrial fibrillation and flutter, other circulatory diseases, chronic obstructive pulmonary disease, kidney disease | 30% reduction in the mean population intake of salt | 24 h urinary sodium between 1 and 5 g per day |
1. Golestan Cohort Study.
2. Isfahan Healthy Heart Program.
3. Monitoring trends and determinants in cardiovascular disease.
4. National Health Survey.
5. The Tehran Lipid and Glucose Study.
6. Persian Gulf Healthy Heart Study.
7. Yazd Healthy Heart Program.
8. Household Income and Expenditure survey.
Figure 3Trends and projections of unconditional probability of dying in four categories of NCDs. (a) Females, (b) Males.
Prevalence of risk factors and mean of salt intake in three time periods by sex.
| Risk factor | 2010 | 2015 | Projected by 2030 | |||
|---|---|---|---|---|---|---|
| F | M | F | M | F | M | |
| Diabetes (%) | 8.9 (8.4–9.3) | 7.3 (6.9–7.8) | 9.5 (9–9.9) | 7.9 (7.5–8.4) | 11.2 (10.8–11.7) | 9.5 (9.0–10.0) |
| Hypertension (%) | 25.4 (23.2–27.5) | 21.0 (19.3–22.7) | 30.0 (27.9–32.1) | 24.8 (23.1–26.4) | 42.5 (39.0–46.1) | 35.2 (32.1–38.5) |
| Obesity (%) | 27.3 (25.0–29.6) | 14.3 (12.9–15.8) | 32.2 (30.1–34.1) | 17.7 (16.3–19.1) | 42.6 (40.2–45.2) | 26.3 (23.8–28.9) |
| Physical inactivity (%) | 50.4 (46.4–54.2) | 38.5 (34.5–42.3) | 58.6 (55.1–61.9) | 46.8 (43.1–50.2) | 75.9 (71.9–79.9) | 65.5 (61.1–70.2) |
| Smoking (%) | 3.7 (3.7–3.7) | 27.1 (25.2–29.0) | 3.3 (3.3–3.3) | 24.3 (22.4–26.3) | 2.4 (2.4–2.4) | 17.6 (15.6–19.5) |
| Mean of salt intake (grams per day) | 9.6 = − (9.5–9.8) | 10.4 (10.2–10.6) | 9.3 (9.1–9.5) | 9.9 (9.7–10.1) | 8.2 (7.6–8.8) | 8.3 (7.7–8.9) |
Avoidable deaths by NCDs categories with reducing the risk factors by 2030.
| Risk factor | Theoretical minim exposure risk level scenarioa | WHO-based scenario10b | WHO-based scenario15c | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancers | CVDs | Asthma and COPD | Diabetes | Cancers | CVDs | Asthma and COPD | Diabetes | Cancers | CVDs | Asthma and COPD | Diabetes | |||||||||||||
| F | M | F | M | F | M | F | M | F | M | F | M | F | M | F | M | F | M | F | M | F | M | F | M | |
| Diabetes | – | 10,443 | 18,611 | – | – | 2455 | 2286 | – | – | 473 | 1159 | – | – | 1044 | 884 | – | – | 145 | 467 | – | – | 702 | 608 | |
| Hypertension | – | – scenario 1 | 27,798 | 26,026 | – | – | 95 | 91 | – | – | 9342 | 9746 | – | – | 35 | 24 | – | – | 8968 | 9186 | – | – | 33 | 23 |
| Obesity | 1949 | 1004 | 7622 | 9550 | – | – | 1964 | 1526 | 752 | 438 | 2085 | 3185 | – | – | 451 | 495 | 277 | 217 | 1649 | 2888 | – | – | 168 | 212 |
| Physical inactivity | 1089 | 832 | 1003 | 326 | – | – | 4545 | 7151 | 798 | 365 | 3591 | 7943 | – | – | 866 | 931 | 606 | 276 | 2737 | 6027 | – | – | 658 | 710 |
| Smoking | 1649 | 757 | 7435 | 4482 | 678 | 385 | 180 | 53 | 158 | 322 | 918 | 1521 | 77 | 135 | 12 | 40 | 173 | 349 | 1010 | 1648 | 84 | 147 | 14 | 44 |
| Mean of salt intake | 334 | 594 | 10,947 | 17,961 | – | – | – | – | 83 | 151 | 6267 | 8566 | – | – | – | – | 117 | 219 | 4612 | 5247 | – | – | – | – |
aAvoidable deaths happen by each risk factor to the theoretical minim exposure risk level.
bWHO-based scenario10: Avoidable deaths happen by reduce each risk factor to WHO recommended level compared 2010.
cWHO-based scenario15: Avoidable deaths happen by reduce each risk factor to WHO recommended level compared 2015.
Figure 4Comparing the projected UPoD (if the current trend goes on) with the UPoD after reducing the avoidable deaths in 2010 WHO-based scenario.
Figure 5Comparing the projected UPoD (if the current trend goes on) with the UPoD after reducing the avoidable deaths in 2015 WHO-based scenario.
Gain in life expectancy after elimination of major causes of death from NCDs.
| Gender | Life expectancy | ||||
|---|---|---|---|---|---|
| Life expectancy in 30–70 age group by 2015 | Female | 39.62 | |||
| Male | 36.30 | ||||
| Life expectancy in 30–70 age group by 2030(projected) | Female | 45.46 | |||
| Male | 40.63 |
Figure 6Achieving SDG 3.4 in current situation in the 2 scenarios. (a) Female in 2010 baseline scenario, (b) male in 2010 baseline scenario, (c) female in 2015 baseline scenario, (d) male in 2015 baseline scenario. The map was generated in R software version 4.0.1 (2020-04), https://cran.r-project.org/bin/windows/base/.
Figure 7Achieving SDG 3.4 in WHO based scenario in the 2 scenarios. (a) Female in 2010 WHO based scenario, (b) male in 2010 WHO based scenario, (c) female in 2015 WHO based scenario, (d) male in 2015 WHO based scenario. The map was generated in R software version 4.0.1 (2020-04), https://cran.r-project.org/bin/windows/base/.